Cantel Medical (CMD) Misses Q2 EPS by 5c

Cantel Medical (NYSE: CMD) reported Q2 EPS of $0.57, $0.05 worse than the analyst estimate of $0.62. Revenue for the quarter came in at $224.5 million versus the consensus estimate of $226.95 million.

For earnings history and earnings-related data on Cantel Medical (CMD) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Five Below (FIVE) Tops Q2 EPS by 35c, Beats on Revenue; Offers Q3 Revenue Guidance
• Netskope, Inc. (NTSK) Tops Q2 EPS by 4c, Offers Guidance